Immunocore Holdings plc American Depositary Shares (IMCR)
Stock · NASDAQ · Health Care
$36.62as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$28.56
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $1.56B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Immunocore Holdings plc American Depositary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub
Immunocore Holdings plc American Depositary Shares Competitors
Chosen by industry and closest market cap.
- IMCRImmunocore Holdings plc American Depositary Shares$36.62▼ 0.35%Market cap $1.56BP/E —
- RXRXRecursion Pharmaceuticals Inc. Class A Common Stock$3.33▼ 3.20%Market cap $1.69BP/E —$2.77$7.18
- GLUEMonte Rosa Therapeutics Inc. Common Stock$13.37▼ 6.63%Market cap $1.30BP/E —$4.6$25.77
- MESOMesoblast Limited American Depositary Shares$17.42▼ 4.18%Market cap $1.87BP/E —$1.88$3.31
- INBXInhibrx Biosciences Inc. Common Stock$123.93▼ 0.00%Market cap $1.21BP/E —$26.19$155.29
- IMTXImmatics N.V. Ordinary Shares$9.45▲ 0.91%Market cap $1.21BP/E —$5.05$12.41
- VORVor Biopharma Inc. Common Stock$22.66▼ 3.70%Market cap $1.16BP/E —$6.5$49.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IMCR Immunocore Holdings plc American Depositary Shares | $1.56B | — | $36.62 | ▼ 0.35% | |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | $1.69B | — | $3.33 | ▼ 3.20% | $2.77$7.18 |
| GLUE Monte Rosa Therapeutics Inc. Common Stock | $1.30B | — | $13.37 | ▼ 6.63% | $4.6$25.77 |
| MESO Mesoblast Limited American Depositary Shares | $1.87B | — | $17.42 | ▼ 4.18% | $1.88$3.31 |
| INBX Inhibrx Biosciences Inc. Common Stock | $1.21B | — | $123.93 | ▼ 0.00% | $26.19$155.29 |
| IMTX Immatics N.V. Ordinary Shares | $1.21B | — | $9.45 | ▲ 0.91% | $5.05$12.41 |
| VOR Vor Biopharma Inc. Common Stock | $1.16B | — | $22.66 | ▼ 3.70% | $6.5$49.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price TargetBenzinga · 8/21/2026
- Immunocore Holdings plc 2026 Q2 - Results - Earnings Call PresentationSeekingAlpha · 8/7/2026
- Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/6/2026
- Immunocore (NASDAQ:IMCR) Q2 Revenue Beats but EPS Misses, Shares TumbleChartMill · 8/6/2026
- Immunocore Hldgs Q2 EPS $(0.02) Misses $0.02 Estimate, Sales $115.927M Beat $110.374M EstimateBenzinga · 8/6/2026
- Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35Benzinga · 8/3/2026
Insider Activity
Insider Actions →Acquired
165.0K
Disposed
0
- Bell John Irving · May 27, 2026 · Grant27.5K
- Kaul Siddharth · May 27, 2026 · Grant27.5K
- Herbst Roy Steven · May 27, 2026 · Grant27.5K
- Ratcliffe Peter John · May 27, 2026 · Grant27.5K
- Pao William · May 27, 2026 · Grant27.5K
- Peterson Kristine · May 27, 2026 · Grant27.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 54.19M
- Total value held
- $1.53B
- Institutional holders
- 142
Top holders this quarter
- Unknown4.87M
- Unknown4.83M
- Unknown4.71M
- Unknown3.69M
- Unknown2.80M
- Unknown2.77M
- Unknown2.65M
- Unknown1.93M
- Unknown1.93M
- Unknown1.89M
See the full, filterable feed with live charts on the MarketWall dashboard.